#EVERSANA #OSTherapies #IterumTherapeutics #OSTHER2 #paediatricosteosarcoma #immunotherapy #OrphanDesignation #FastTrackDesignation #RarePediatricDiseaseDesignation #BLAsubmission #EVERSANAONCOLOGY #ORLYNVAH #ProductCommercializationAgreement #oralpenemantibiotic
pharmaphorum.com/market-acces...
pharmaphorum.com/market-acces...
EVERSANA expands commercialisation portfolio with OS Therapies and Iterum Therapeutics partnerships
pharmaphorum.com
July 1, 2025 at 9:19 AM